Vascular robotics: Robocath unveils survey findings on users’ current expectations and future developments
15 May 2024
Rouen, France, May 15, 2024 – Robocath, a company that designs, develops and markets innovative robotic solutions to treat cardiovascular and neurovascular diseases, today announces the publication of a new report into current and future expectations for the use of robotics in interventional medicine.
The report sets out the findings from an independent study conducted by Suazio Consulting. It involved 30 interventional cardiologists based in the US, Europe and Asia.
The study reveals growing support for the use of robotics…
